Lithium diisopropylamide → 4-[2-[5,6-Dimethyl-1,2-benzisoxazol-3-yl]ethyl]-1-piperidinecarboxylic acid, 1-(1,1-dimethylethyl) ester

HRID 2268164ノート

反応式

HRID 2268164 の反応式
[CH3:1][C:2]1[C:6]2[CH:7]=[C:8]([CH3:12])[C:9]([CH3:11])=[CH:10][C:5]=2[O:4][N:3]=1.I[CH2:14][CH:15]1[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17][CH2:16]1.[Li+].CC([N-]C(C)C)C>C1COCC1>[CH3:12][C:8]1[C:9]([CH3:11])=[CH:10][C:5]2[O:4][N:3]=[C:2]([CH2:1][CH2:14][CH:15]3[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:25])([CH3:27])[CH3:26])=[O:22])[CH2:17][CH2:16]3)[C:6]=2[CH:7]=1

参加物

5

反応物 3

HCID 2724682Lithium diisopropylamideHCID 10448961Tert-butyl 4-(iodomethyl)piperidine-1-carboxylateHCID 123854753,5,6-Trimethylbenzo[d]isoxazole

生成物 1

HCID 102478404-[2-[5,6-Dimethyl-1,2-benzisoxazol-3-yl]ethyl]-1-piperidinecarboxylic acid, 1-(1,1-dimethylethyl) ester収率 78%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

実験手順

The procedure described in Example 1d was followed using 3,5,6-trimethyl-1,2-benzisoxazole (0.600 g, 3.73 mmol), 4-iodomethyl-1-piperidinecarboxylic acid, 1-(1,1-dimethylethyl) ester (1.30 g, 4.10 mmol), and 1M LDA (4.10 mL, 4.10 mmol) in dry THF (10 mL). After purification, the title compound (1.04 g, 78%) was obtained as a clear oil.

後処理

  1. customAfter purification

出典と根拠

ORDレコード
ord-ea0ffddbdf42435bb5b6f7ec14c7f3bb
出典データセット
uspto-grants-2001_12
特許番号
US06326382B1

反応ノート

読み込み中…